WATSON 414 (Estropipate 0.75 mg)
Pill imprint WATSON 414 has been identified as Estropipate 0.75 mg.
Estropipate is used in the treatment of postmenopausal symptoms; oophorectomy; osteoporosis; atrophic urethritis; hypoestrogenism (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 0.75 mg is not subject to the Controlled Substances Act.
See also related documents.